Cite
MLA Citation
David Bernard Miklos et al.. “Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.” Journal of clinical oncology, vol. 41, no. 10, 2023, pp. 1876–1887. http://access.bl.uk/ark:/81055/vdc_100184353345.0x00001f